Evidence map›Paper›PMID 23532470›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2013

Clostridium difficile infection is associated with increased risk of death and prolonged hospitalization in children.

Julia Shaklee Sammons, Russell Localio, Rui Xiao, Susan E Coffin, Theoklis Zaoutis

Open access · bronzeAbstract readMulticenter Study
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 6 pooled it
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 6 syntheses or guidelines pooled it, 112 citations in OpenAlex.

  1. Pooled it
  2. Global burden ofJournal of global health · 2019
    Pooled it
  3. Guideline
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Article
  10. Article
  11. Article
  12. Healthcare-AssociatedMicroorganisms · 2025
    Article
  13. Review
  14. Article
  15. Economic Burden of Clostridioides difficile Infection in European Countries.Advances in experimental medicine and biology · 2024
    Article
  16. Strategies to preventInfection control and hospital epidemiology · 2023
    Article
  17. A systematic review of real-world healthcare resource use and costs ofAntimicrobial stewardship & healthcare epidemiology : ASHE · 2023
    Article
  18. Article
  19. Iron Effects onAntibiotics (Basel, Switzerland) · 2022
    Article
  20. ReducingInfection control and hospital epidemiology · 2020
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Julia Shaklee SammonsDivision of Infectious Diseases, and Department of Perelman School of Medicine, University of Pennsylvania, Pennsylvania, USA.
Russell Localio
Rui Xiao
Susan E Coffin
Theoklis Zaoutis
University of Pennsylvania · USInfection Prevention Society · GB

Funding

Infectious Diseases Epidemiology Training GrantT32AI055435 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI LAUTENBACH, EBBING · 2003 to 2023
$6.9M
NIAID NIH HHS 5T32AI-055435-08NIAID NIH HHS T32 AI055435
6 · The paper itself

Abstract

backgroundClostridium difficile infection (CDI) is associated with significant morbidity and mortality among adults. However, outcomes are poorly defined among children.

methodsA retrospective cohort study was performed among hospitalized children at 41 children's hospitals between January 2006 and August 2011. Patients with CDI (exposed) were matched 1:2 to patients without CDI (unexposed) based on the probability of developing CDI (propensity score derived from patient characteristics). Exposed subjects were stratified by C. difficile test date, suggestive of community-onset (CO) versus hospital-onset (HO) CDI. Outcomes were analyzed for matched subjects.

resultsWe identified 5107 exposed and 693 409 unexposed subjects. Median age was 6 years (interquartile range [IQR], 2-13 years) for exposed and 8 years (IQR, 3-14 years) for unexposed subjects. Of these, 4474 exposed were successfully matched to 8821 unexposed by propensity score. In-hospital mortality differed significantly (CDI, 1.43% vs matched unexposed, 0.66%; P < .001). Mortality rates were similar between CO-CDI and matched subjects. However, mortality rates were significantly greater among HO-CDI compared with matched unexposed (odds ratio, 6.73 [95% confidence interval {CI}, 3.77-12.02]). Mean differences in length of stay (LOS) and total cost were significant: 5.55 days (95% CI, 4.54-6.56 days) and $18 900 (95% CI, $15 100-$22 700) for CO-CDI, and 21.60 days (95% CI, 19.29-23.90 days) and $93 600 (95% CI, $80 000-$107 200) for HO-CDI.

conclusionsPediatric CDI is associated with increased mortality, longer LOS, and higher costs. These findings underscore the importance of antibiotic stewardship and infection control programs to prevent this disease in children.

Indexed as

Length of StayAdolescentChildChild, PreschoolClostridioides difficileClostridium InfectionsCohort StudiesFemaleHealth Care CostsHumansMaleRetrospective StudiesSurvival AnalysisC. difficile infectionepidemiologyoutcomespediatrics

Identifiers

PMID23532470
PMCPMC3669523
OpenAlexW2151297416

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.